AarXiv2023Cited 8×

Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice

Marie-Astrid Decrocq-Rudler, Anna H-X. P. Chan Kwong, Lucy Meunier, Julien Fraisse, José Ursic‐Bedoya, Sonia Khier

Abstract

'Julien Fraisse' 'José Ursic‐Bedoya' 'Sonia Khier'] - 1. Pharmacokinetic and Modeling Department, School of Pharmacy, Montpellier University, Montpellier, France - 2. Probabilities and Statistics Department, Institut Montpellierain Alexander Grothendieck (IMAG), CNRS UMR 5149, Montpellier University, Montpellier, France - 3. SMARTc group, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Aix-Marseille University, Marseille, France - 4. Department of Hepato-Gastroenterology and Liver Transplantation, Montpellier University Hospital (Saint Eloi), Montpellier, France - 5. Altran-Capgemini, Montpellier, France

A figure from Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice — fig. from the paper

§ The Valyu brief

The paper, in five minutes

Read from the full text via Valyu Contents

Tweaking a published tacrolimus PK model with NONMEM’s PRIOR method markedly improves prediction accuracy for liver transplant patients.

What’s new

i.Selected an existing population PK model for tacrolimus in adult liver transplant patients.
ii.Implemented model tweaking using the PRIOR subroutine in NONMEM with full informative and optimized weighting strategies.
iii.Demonstrated improved a priori and Bayesian prediction performance on an external validation set.
iv.Provided quantitative bias and imprecision reductions compared to the original literature model.

How they did it

Retrospectively collected therapeutic drug monitoring data from 79 liver‑transplanted adults (851 concentrations). Seventy‑percent of the data were used to adjust the literature PK model via NONMEM’s PRIOR subroutine (full informative and optimized weighting), and the remaining thirty percent served for external validation of a priori and Bayesian forecasts.

What they found

79 patients, 851 tacrolimus concentrations analyzed.
A priori bias improved from –41% (literature model) to –28.5% (full informative) and –8.73% (optimized).
A priori imprecision decreased from 45.4% to 38.0% (full informative) and 39.2% (optimized).
Bayesian forecasts became acceptable from the third prediction (≥2 prior concentrations), about 1 week post‑transplant.

§ The Valyu brief

Reading the full paper and taking notes. This takes a few seconds…

§ Ask this paper

Ask a question about this paper

Valyu reads the full text and answers from what the paper actually says.

§ Related work in other archives

Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice

The paper, in five minutes

Ask a question about this paper

Similar papers in all four archives

The paper, in five minutes

Similar papers in all four archives